Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Schultz

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Legal Medicine|September 1, 1976
Some legal implications of computerizing medical recordsR S Merchant, R W Schultz
JAMA|December 28, 1970
A safe peritoneal access device for repeated peritoneal dialysisD G Vidt, J Somerville, R W Schultz
Antimicrobial Agents and Chemotherapy|December 1, 1990
Pharmacokinetics of lomefloxacin in renally compromised patientsR A Blum, R W Schultz, J J Schentag
Antimicrobial Agents and Chemotherapy|February 1, 1984
Pharmacokinetics of ceftazidime in patients with renal insufficiencyL S Welage, R W Schultz, J J Schentag
Radiology|May 1, 1982
Massive hemorrhage from jejunal diverticulaR M Spiegel, R W Schultz, W J Casarella, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1981
Mezlocillin disposition in chronic hemodialysis patientsD M Janicke, A Mangione, R W Schultz, et al.
AJR. American Journal of Roentgenology|September 1, 1981
Percutaneous dilatation in primary sclerosing cholangitis: two experiencesE C Martin, E I Fankuchen, R W Schultz, et al.
Therapeutic Drug Monitoring|January 1, 1980
Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusionK M Pizzella, M C Moore, R W Schultz, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysisD P Reitberg, D A Marble, R W Schultz, et al.
Surgery, Gynecology & Obstetrics|January 1, 1982
Percutaneous abscess drainageK B Karlson, E C Martin, E I Fankuchen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Legal Medicine|September 1, 1976
Some legal implications of computerizing medical recordsR S Merchant, R W Schultz
JAMA|December 28, 1970
A safe peritoneal access device for repeated peritoneal dialysisD G Vidt, J Somerville, R W Schultz
Antimicrobial Agents and Chemotherapy|December 1, 1990
Pharmacokinetics of lomefloxacin in renally compromised patientsR A Blum, R W Schultz, J J Schentag
Antimicrobial Agents and Chemotherapy|February 1, 1984
Pharmacokinetics of ceftazidime in patients with renal insufficiencyL S Welage, R W Schultz, J J Schentag
Radiology|May 1, 1982
Massive hemorrhage from jejunal diverticulaR M Spiegel, R W Schultz, W J Casarella, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1981
Mezlocillin disposition in chronic hemodialysis patientsD M Janicke, A Mangione, R W Schultz, et al.
AJR. American Journal of Roentgenology|September 1, 1981
Percutaneous dilatation in primary sclerosing cholangitis: two experiencesE C Martin, E I Fankuchen, R W Schultz, et al.
Therapeutic Drug Monitoring|January 1, 1980
Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusionK M Pizzella, M C Moore, R W Schultz, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysisD P Reitberg, D A Marble, R W Schultz, et al.
Surgery, Gynecology & Obstetrics|January 1, 1982
Percutaneous abscess drainageK B Karlson, E C Martin, E I Fankuchen, et al.
Pageof 2